Targeted KIT inhibitors: paradigm shift in the treatment of systemic mastocytosis

Hussein A. Abbas, Helen T. Chifotides, Prithviraj Bose

Open source

DOI: 10.1080/13543784.2026.2761888
Published: 2026-11-10
Container: Expert Opinion on Investigational Drugs
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/13543784.2026.2761888,
  title = {Targeted KIT inhibitors: paradigm shift in the treatment of systemic mastocytosis},
  author = {Hussein A. Abbas and Helen T. Chifotides and Prithviraj Bose},
  year = {2026},
  journal = {Expert Opinion on Investigational Drugs},
  doi = {10.1080/13543784.2026.2761888},
  url = {https://doi.org/10.1080/13543784.2026.2761888}
}

RIS

TY  - JOUR
TI  - Targeted KIT inhibitors: paradigm shift in the treatment of systemic mastocytosis
AU  - Hussein A. Abbas
AU  - Helen T. Chifotides
AU  - Prithviraj Bose
PY  - 2026
JO  - Expert Opinion on Investigational Drugs
DO  - 10.1080/13543784.2026.2761888
UR  - https://doi.org/10.1080/13543784.2026.2761888
ER  -

APA

Abbas, H. A., Chifotides, H. T., & Bose, P. (2026). Targeted KIT inhibitors: paradigm shift in the treatment of systemic mastocytosis. Expert Opinion on Investigational Drugs. https://doi.org/10.1080/13543784.2026.2761888

Source records

crossref · retrieved 2026-11-10T18:54:06.298Z